These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19572825)

  • 1. Implementation of CYP2D6 genotyping in psychiatry.
    Loovers HM; van der Weide J
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1065-77. PubMed ID: 19572825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic.
    Müller DJ; Kekin I; Kao AC; Brandl EJ
    Int Rev Psychiatry; 2013 Oct; 25(5):554-71. PubMed ID: 24151801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of CYP450 testing in the clinical setting.
    Samer CF; Lorenzini KI; Rollason V; Daali Y; Desmeules JA
    Mol Diagn Ther; 2013 Jun; 17(3):165-84. PubMed ID: 23588782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry. Current issues in clinical implementation.
    de Leon J
    CNS Spectr; 2006 Mar; 11(3 Suppl 3):8-12. PubMed ID: 17760224
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.
    de Leon J; Armstrong SC; Cozza KL
    Psychosomatics; 2006; 47(1):75-85. PubMed ID: 16384813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype.
    van der Weide J; van Baalen-Benedek EH; Kootstra-Ros JE
    Ther Drug Monit; 2005 Aug; 27(4):478-83. PubMed ID: 16044105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-metabolizing enzyme genotypes and aggressive behavior treatment response in hospitalized pediatric psychiatric patients.
    Prows CA; Nick TG; Saldaña SN; Pathak S; Liu C; Zhang K; Daniels ZS; Vinks AA; Glauser TA
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):385-94. PubMed ID: 19702490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
    Hicks JK; Swen JJ; Thorn CF; Sangkuhl K; Kharasch ED; Ellingrod VL; Skaar TC; Müller DJ; Gaedigk A; Stingl JC;
    Clin Pharmacol Ther; 2013 May; 93(5):402-8. PubMed ID: 23486447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA microarray technology in the clinical environment: the AmpliChip CYP450 test for CYP2D6 and CYP2C19 genotyping.
    de Leon J; Susce MT; Johnson M; Hardin M; Maw L; Shao A; Allen AC; Chiafari FA; Hillman G; Nikoloff DM
    CNS Spectr; 2009 Jan; 14(1):19-34. PubMed ID: 19169185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genotyping of CYP2D6 and CYP2C19].
    Slanar O; Drazd'áková M; Babiárová K; Pechandová K; Buzková H; Perlík F; Zima T
    Cas Lek Cesk; 2007; 146(9):708-11. PubMed ID: 17966194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized pharmacotherapy in psychiatry.
    Filaković P; Petek A
    Psychiatr Danub; 2009 Sep; 21(3):341-6. PubMed ID: 19794353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study.
    Tamminga WJ; Wemer J; Oosterhuis B; de Boer A; Vranckx S; Drenth BF; de Zeeuw RA; de Leij LF; Jonkman JH
    Eur J Clin Pharmacol; 2003 May; 59(1):57-64. PubMed ID: 12743673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is pharmacogenetic CYP2D6 testing useful?
    Vetti HH; Molven A; Eliassen AK; Steen VM
    Tidsskr Nor Laegeforen; 2010 Nov; 130(22):2224-8. PubMed ID: 21109842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.
    Schroth W; Antoniadou L; Fritz P; Schwab M; Muerdter T; Zanger UM; Simon W; Eichelbaum M; Brauch H
    J Clin Oncol; 2007 Nov; 25(33):5187-93. PubMed ID: 18024866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have we successfully implemented CYP2D6 genotyping in psychiatry?
    de Leon J
    Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1201-1203. PubMed ID: 29164956
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytochrome P-450 2D6 and 2C19 polymorphisms and length of hospitalization in psychiatry.
    Kropp S; Lichtinghagen R; Winterstein K; Schlimme J; Schneider U
    Clin Lab; 2006; 52(5-6):237-40. PubMed ID: 16812949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry. Practical issues related to medication selection.
    Smoller JW
    CNS Spectr; 2006 Mar; 11(3 Suppl 3):5-7. PubMed ID: 17760223
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
    Kirchheiner J; Nickchen K; Bauer M; Wong ML; Licinio J; Roots I; Brockmöller J
    Mol Psychiatry; 2004 May; 9(5):442-73. PubMed ID: 15037866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
    Schenk PW; van Fessem MA; Verploegh-Van Rij S; Mathot RA; van Gelder T; Vulto AG; van Vliet M; Lindemans J; Bruijn JA; van Schaik RH
    Mol Psychiatry; 2008 Jun; 13(6):597-605. PubMed ID: 17667959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.